SCHEMBL662961

SCHEMBL662961

Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(C#CCCO[N+](=O)OCCC#Cc2ccc(-c3c(C)c(C(=O)NN4CCCCC4)nn3-c3ccc(Cl)cc3Cl)cc2)cc1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 14/20 0.82
CNR2 P34972 3/20 0.70
CYP2C9 P11712 2/20 0.70
GPR55 Q9Y2T6 2/20 0.70
ABCC4 O15439 1/20 0.70
MLNR O43193 1/20 0.70
ABCB11 O95342 1/20 0.70
CHRM2 P08172 1/20 0.70
ADORA3 P0DMS8 1/20 0.70
ADRA2B P18089 1/20 0.70
ADRA2C P18825 1/20 0.70
DRD1 P21728 1/20 0.70
TBXA2R P21731 1/20 0.70
SLC6A2 P23975 1/20 0.70
HRH2 P25021 1/20 0.70
HTR2A P28223 1/20 0.70
AGTR1 P30556 1/20 0.70
CCKAR P32238 1/20 0.70
CCKBR P32239 1/20 0.70
MC4R P32245 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29471328 0.94 CNR1 (0.80) CNR1CNR2CYP2C9GPR55ABCC4
SCHEMBL662960 0.94 CNR1 (0.80) CNR1CNR2CYP2C9GPR55ABCC4
SCHEMBL16152256 0.93 CNR1 (0.87) CNR1CNR2CYP2C9GPR55ABCC4
SCHEMBL662094 0.91 CNR1 (0.81) CNR1CNR2CYP2C9GPR55ABCC4
SCHEMBL662749 0.90 CNR1 (0.87) CNR1CNR2CYP2C9GPR55ABCC4
SCHEMBL31529035 0.90 CNR1 (0.76) CNR1CNR2CYP2C9GPR55ABCC4
SCHEMBL16136717 0.90 CNR1 (0.68) CNR1CNR2CYP2C9GPR55ABCC4
SCHEMBL2627909 0.89 CNR1 (1.00) CNR1CNR2CYP2C9GPR55ABCC4
SCHEMBL10138879 0.89 CNR1 (0.88) CNR1CNR2CYP2C9GPR55ABCC4
SCHEMBL31528987 0.89 CNR1 (1.00) CNR1CNR2CYP2C9GPR55ABCC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10053444-B2 Cannabinergic nitrate esters and related analogs UNIVERSITY OF CONNECTICUT (US) 2018-08-21 US disclosed
US-20170001980-A9 Novel Cannabinergic Nitrate Esters and Related Analogs UNIVERSITY OF CONNECTICUT 2017-01-05 US disclosed
US-20160096822-A1 Novel Cannabinergic Nitrate Esters and Related Analogs MAKRIYANNIS ALEXANDROS (US) 2016-04-07 US disclosed
US-8853205-B2 Heteropyrrole analogs acting on cannabinoid receptors UNIVERSITY OF CONNECTICUT (US) 2014-10-07 US disclosed
US-20120046280-A1 NOVEL HETEROPYRROLE ANALOGS ACTING ON CANNABINOID RECEPTORS UNIVERSITY OF CONNECTICUT 2012-02-23 US disclosed
EP-2398323-A1 NOVEL HETERO PYRROLE ANALOGS ACTING ON CANNAPINOID RECEPTORS University of Connecticut (US) 2011-12-28 EP disclosed
WO-2010104488-A1 NOVEL HETERO PYRROLE ANALOGS ACTING ON CANNAPINOID RECEPTORS UNIVERSITY OF CONNECTICUT (US) 2010-09-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046280-A1 NOVEL HETEROPYRROLE ANALOGS ACTING ON CANNABINOID RECEPTORS CNR1, CNR2, CBR3 CNR1 1/4885CNR2 2/4885CYP2C9 654/4885
US-10053444-B2 Cannabinergic nitrate esters and related analogs CNR2, CNR1, NOS3 CNR1 2/4885CNR2 1/4885CYP2C9 239/4885
US-20160096822-A1 Novel Cannabinergic Nitrate Esters and Related Analogs CNR2, CNR1, CHRNB4 CNR1 2/4885CNR2 1/4885CYP2C9 415/4885
US-20170001980-A9 Novel Cannabinergic Nitrate Esters and Related Analogs CNR2, CNR1, CHRNB4 CNR1 2/4885CNR2 1/4885CYP2C9 415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.